The ongoing second part of the study is evaluating MariTide beyond 52 weeks, looking at additional weight loss with continued treatment, weight maintenance using less frequent or lower dosing and durability of weight loss following treatment discontinuation
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have moved well beyond diabetes management
For patients with type 2 diabetes taking semaglutide, understanding how different carbohydrates affect blood glucose remains important despite the medication's glucose-lowering effects
Instead, your providers will recommend whatever therapy is truly best for you on your weight loss journey
Ask About Extended Dosing Once our patients are at goal weight and they tell us they want to save some money, we start doing a trial to see if they can maintain their weight loss at a longer interval, says Vincent Bottaro (PA-C), from the Rivas Towson (Md.) clinic